Home » Topics » BioWorld Science

BioWorld Science
RSS

New LRRK2 inhibitors patented by GlaxoSmithKline

Aug. 22, 2018

Sihuan initiates phase II trial with anaprazole in China

Aug. 22, 2018

At ACS national meeting, researchers share their successes

Aug. 22, 2018

Boehringer Ingelheim discovers new FFAR1 agonists

Aug. 22, 2018

Lixte partners with Moffitt for phase Ib/II study of LB-100 in low and intermediate-1 risk MDS

Aug. 22, 2018

GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain

Aug. 22, 2018

ProMIS Neurosciences reports positive results for PMN-310 in Alzheimer's disease

Aug. 22, 2018

Ichor announces utilization of TriGrid delivery system in a phase I/IIb study of GX-188E vaccine

Aug. 22, 2018

Amgen initiates first-in-human studies with AMG-424 and AMG-397

Aug. 22, 2018

Viela Bio initiates first-in-human study of VIB-9600

Aug. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...